Jenny Roggisch, Thorsten Ecke, Stefan Koch. Urol Oncol 2020
Times Cited: 5
Times Cited: 5
Times Cited
Times Co-cited
Similarity
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
Françoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, Eric Piaton, Florence Geiguer, Claire Rodriguez-Lafrasse, Jean E Terrier, Jonathan Lopez, Alain Ruffion. Br J Cancer 2017
Françoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, Eric Piaton, Florence Geiguer, Claire Rodriguez-Lafrasse, Jean E Terrier, Jonathan Lopez, Alain Ruffion. Br J Cancer 2017
60
Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
60
40
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Cheryl M Koh, Ekta Khattar, Shi Chi Leow, Chia Yi Liu, Julius Muller, Wei Xia Ang, Yinghui Li, Guido Franzoso, Shang Li, Ernesto Guccione,[...]. J Clin Invest 2015
Cheryl M Koh, Ekta Khattar, Shi Chi Leow, Chia Yi Liu, Julius Muller, Wei Xia Ang, Yinghui Li, Guido Franzoso, Shang Li, Ernesto Guccione,[...]. J Clin Invest 2015
40
Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Liang Cheng, Darrell D Davidson, Mingsheng Wang, Antonio Lopez-Beltran, Rodolfo Montironi, Lisha Wang, Puay-Hoon Tan, Gregory T MacLennan, Sean R Williamson, Shaobo Zhang. Histopathology 2016
Liang Cheng, Darrell D Davidson, Mingsheng Wang, Antonio Lopez-Beltran, Rodolfo Montironi, Lisha Wang, Puay-Hoon Tan, Gregory T MacLennan, Sean R Williamson, Shaobo Zhang. Histopathology 2016
40
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
40
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation.
Ilaria J Russo, Yongwon Ju, Naheema S Gordon, Maurice P Zeegers, K K Cheng, Nicholas D James, Richard T Bryan, Douglas G Ward. Bladder Cancer 2018
Ilaria J Russo, Yongwon Ju, Naheema S Gordon, Maurice P Zeegers, K K Cheng, Nicholas D James, Richard T Bryan, Douglas G Ward. Bladder Cancer 2018
40
Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Boaz Kurtis, Jian Zhuge, Caroline Ojaimi, Fei Ye, Dongming Cai, David Zhang, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2016
Boaz Kurtis, Jian Zhuge, Caroline Ojaimi, Fei Ye, Dongming Cai, David Zhang, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2016
40
Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
40
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz,[...]. Cancer Res 2013
Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz,[...]. Cancer Res 2013
40
TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
Kun Wang, Tiantian Liu, Cheng Liu, Yan Meng, Xiaotian Yuan, Li Liu, Nan Ge, Jikai Liu, Chang Wang, Hongbo Ren,[...]. Oncologist 2015
Kun Wang, Tiantian Liu, Cheng Liu, Yan Meng, Xiaotian Yuan, Li Liu, Nan Ge, Jikai Liu, Chang Wang, Hongbo Ren,[...]. Oncologist 2015
40
Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
Ricardo Leão, Donghyun Lee, Arnaldo Figueiredo, Thomas Hermanns, Peter Wild, Martin Komosa, Irene Lau, Mathew Mistry, Nuno Miguel Nunes, Aryeh J Price,[...]. Int J Cancer 2019
Ricardo Leão, Donghyun Lee, Arnaldo Figueiredo, Thomas Hermanns, Peter Wild, Martin Komosa, Irene Lau, Mathew Mistry, Nuno Miguel Nunes, Aryeh J Price,[...]. Int J Cancer 2019
40
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
Rossana Critelli, Francesca Fasanelli, Marco Oderda, Silvia Polidoro, Manuela Bianca Assumma, Clara Viberti, Mirko Preto, Paolo Gontero, Giuseppina Cucchiarale, Irene Lurkin,[...]. Oncotarget 2016
Rossana Critelli, Francesca Fasanelli, Marco Oderda, Silvia Polidoro, Manuela Bianca Assumma, Clara Viberti, Mirko Preto, Paolo Gontero, Giuseppina Cucchiarale, Irene Lurkin,[...]. Oncotarget 2016
40
Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
40
Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks.
Jia-Min Zhang, Lee Zou. Cell Biosci 2020
Jia-Min Zhang, Lee Zou. Cell Biosci 2020
20
Genes involved in senescence and immortalization.
A S Lundberg, W C Hahn, P Gupta, R A Weinberg. Curr Opin Cell Biol 2000
A S Lundberg, W C Hahn, P Gupta, R A Weinberg. Curr Opin Cell Biol 2000
20
G-quadruplex formation at the 3' end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase.
Quan Wang, Jia-quan Liu, Zhao Chen, Ke-wei Zheng, Chang-yue Chen, Yu-Hua Hao, Zheng Tan. Nucleic Acids Res 2011
Quan Wang, Jia-quan Liu, Zhao Chen, Ke-wei Zheng, Chang-yue Chen, Yu-Hua Hao, Zheng Tan. Nucleic Acids Res 2011
20
Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice.
Eva González-Suárez, Christoph Geserick, Juana M Flores, María A Blasco. Oncogene 2005
Eva González-Suárez, Christoph Geserick, Juana M Flores, María A Blasco. Oncogene 2005
20
Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT.
K Fujimoto, S Kyo, M Takakura, T Kanaya, Y Kitagawa, H Itoh, M Takahashi, M Inoue. Nucleic Acids Res 2000
K Fujimoto, S Kyo, M Takakura, T Kanaya, Y Kitagawa, H Itoh, M Takahashi, M Inoue. Nucleic Acids Res 2000
20
Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients.
D Ma, W Zhu, S Hu, X Yu, Y Yang. J Endocrinol Invest 2013
D Ma, W Zhu, S Hu, X Yu, Y Yang. J Endocrinol Invest 2013
20
Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.
Nicolas Sluis-Cremer, N Alpay Temiz, Ivet Bahar. Curr HIV Res 2004
Nicolas Sluis-Cremer, N Alpay Temiz, Ivet Bahar. Curr HIV Res 2004
20
Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells.
Stacy M Horner, Rosa Anna DeFilippis, Laertes Manuelidis, Daniel DiMaio. J Virol 2004
Stacy M Horner, Rosa Anna DeFilippis, Laertes Manuelidis, Daniel DiMaio. J Virol 2004
20
Conditional telomerase induction causes proliferation of hair follicle stem cells.
Kavita Y Sarin, Peggie Cheung, Daniel Gilison, Eunice Lee, Ruth I Tennen, Estee Wang, Maja K Artandi, Anthony E Oro, Steven E Artandi. Nature 2005
Kavita Y Sarin, Peggie Cheung, Daniel Gilison, Eunice Lee, Ruth I Tennen, Estee Wang, Maja K Artandi, Anthony E Oro, Steven E Artandi. Nature 2005
20
Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Xiao-Qin Wu, Cheng Huang, Xu He, Yuan-Yao Tian, De-Xi Zhou, Yong He, Xin-Hua Liu, Jun Li. Cell Signal 2013
Xiao-Qin Wu, Cheng Huang, Xu He, Yuan-Yao Tian, De-Xi Zhou, Yong He, Xin-Hua Liu, Jun Li. Cell Signal 2013
20
The non-reverse transcriptase activity of the human telomerase reverse transcriptase promotes tumor progression (review).
Yong Qin, Hong Guo, Bo Tang, Shi-Ming Yang. Int J Oncol 2014
Yong Qin, Hong Guo, Bo Tang, Shi-Ming Yang. Int J Oncol 2014
20
Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists.
Z Gunnur Dikmen, Taner Ozgurtas, Sergei M Gryaznov, Brittney-Shea Herbert. Biochim Biophys Acta 2009
Z Gunnur Dikmen, Taner Ozgurtas, Sergei M Gryaznov, Brittney-Shea Herbert. Biochim Biophys Acta 2009
20
Telomere biology: Rationale for diagnostics and therapeutics in cancer.
Philippe Rousseau, Chantal Autexier. RNA Biol 2015
Philippe Rousseau, Chantal Autexier. RNA Biol 2015
20
The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence.
Bruno Bernardes de Jesus, Kerstin Schneeberger, Elsa Vera, Agueda Tejera, Calvin B Harley, Maria A Blasco. Aging Cell 2011
Bruno Bernardes de Jesus, Kerstin Schneeberger, Elsa Vera, Agueda Tejera, Calvin B Harley, Maria A Blasco. Aging Cell 2011
20
Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations.
Lina Basel-Vanagaite, Inderjeet Dokal, Hannah Tamary, Abraham Avigdor, Ben Zion Garty, Alexander Volkov, Tom Vulliamy. Haematologica 2008
Lina Basel-Vanagaite, Inderjeet Dokal, Hannah Tamary, Abraham Avigdor, Ben Zion Garty, Alexander Volkov, Tom Vulliamy. Haematologica 2008
20
Dyskerin Mutations Present in Dyskeratosis Congenita Patients Increase Oxidative Stress and DNA Damage Signalling in Dictyostelium Discoideum.
Javier Rodriguez-Centeno, Rosario Perona, Leandro Sastre. Cells 2019
Javier Rodriguez-Centeno, Rosario Perona, Leandro Sastre. Cells 2019
50
Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
Brahma N Singh, Sharmila Shankar, Rakesh K Srivastava. Biochem Pharmacol 2011
Brahma N Singh, Sharmila Shankar, Rakesh K Srivastava. Biochem Pharmacol 2011
20
Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization.
L A Bryce, N Morrison, S F Hoare, S Muir, W N Keith. Neoplasia 2000
L A Bryce, N Morrison, S F Hoare, S Muir, W N Keith. Neoplasia 2000
20
Involvement of 14-3-3 proteins in nuclear localization of telomerase.
H Seimiya, H Sawada, Y Muramatsu, M Shimizu, K Ohko, K Yamane, T Tsuruo. EMBO J 2000
H Seimiya, H Sawada, Y Muramatsu, M Shimizu, K Ohko, K Yamane, T Tsuruo. EMBO J 2000
20
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Salvatore Piscuoglio, Charlotte Ky Ng, Melissa Murray, Kathleen A Burke, Marcia Edelweiss, Felipe C Geyer, Gabriel S Macedo, Akiko Inagaki, Anastasios D Papanastasiou, Luciano G Martelotto,[...]. J Pathol 2016
Salvatore Piscuoglio, Charlotte Ky Ng, Melissa Murray, Kathleen A Burke, Marcia Edelweiss, Felipe C Geyer, Gabriel S Macedo, Akiko Inagaki, Anastasios D Papanastasiou, Luciano G Martelotto,[...]. J Pathol 2016
20
Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma.
R Villa, C D Porta, M Folini, M G Daidone, N Zaffaroni. J Invest Dermatol 2001
R Villa, C D Porta, M Folini, M G Daidone, N Zaffaroni. J Invest Dermatol 2001
20
Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control.
Orit Uziel, Joelle Attal Singer, Vladimir Danicek, Gideon Sahar, Evgeny Berkov, Michael Luchansky, Abigail Fraser, Ron Ram, Meir Lahav. Exp Gerontol 2007
Orit Uziel, Joelle Attal Singer, Vladimir Danicek, Gideon Sahar, Evgeny Berkov, Michael Luchansky, Abigail Fraser, Ron Ram, Meir Lahav. Exp Gerontol 2007
20
The Telomeric Complex and Metabolic Disease.
Henriette Kirchner, Fozia Shaheen, Hannes Kalscheuer, Sebastian M Schmid, Henrik Oster, Hendrik Lehnert. Genes (Basel) 2017
Henriette Kirchner, Fozia Shaheen, Hannes Kalscheuer, Sebastian M Schmid, Henrik Oster, Hendrik Lehnert. Genes (Basel) 2017
20
Perspectives on sesquiterpene lactones in inflammation and cancer.
Irmgard Merfort. Curr Drug Targets 2011
Irmgard Merfort. Curr Drug Targets 2011
20
The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Cory L Grand, Haiyong Han, Rubén M Muñoz, Steve Weitman, Daniel D Von Hoff, Laurence H Hurley, David J Bearss. Mol Cancer Ther 2002
Cory L Grand, Haiyong Han, Rubén M Muñoz, Steve Weitman, Daniel D Von Hoff, Laurence H Hurley, David J Bearss. Mol Cancer Ther 2002
20
Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.
Yinghui Li, Vinay Tergaonkar. Cancer Res 2014
Yinghui Li, Vinay Tergaonkar. Cancer Res 2014
20
Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
T Tauchi, K Shin-ya, G Sashida, M Sumi, S Okabe, J H Ohyashiki, K Ohyashiki. Oncogene 2006
T Tauchi, K Shin-ya, G Sashida, M Sumi, S Okabe, J H Ohyashiki, K Ohyashiki. Oncogene 2006
20
RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells.
Rajika Arora, Yongwoo Lee, Harry Wischnewski, Catherine M Brun, Tobias Schwarz, Claus M Azzalin. Nat Commun 2014
Rajika Arora, Yongwoo Lee, Harry Wischnewski, Catherine M Brun, Tobias Schwarz, Claus M Azzalin. Nat Commun 2014
20
Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.
C Strahl, E H Blackburn. Mol Cell Biol 1996
C Strahl, E H Blackburn. Mol Cell Biol 1996
20
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.
Zhihu Ding, Chang-Jiun Wu, Mariela Jaskelioff, Elena Ivanova, Maria Kost-Alimova, Alexei Protopopov, Gerald C Chu, Guocan Wang, Xin Lu, Emma S Labrot,[...]. Cell 2012
Zhihu Ding, Chang-Jiun Wu, Mariela Jaskelioff, Elena Ivanova, Maria Kost-Alimova, Alexei Protopopov, Gerald C Chu, Guocan Wang, Xin Lu, Emma S Labrot,[...]. Cell 2012
20
Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
Lloyd Kelland. Clin Cancer Res 2007
Lloyd Kelland. Clin Cancer Res 2007
20
Potential of telomerase activation in extending health span and longevity.
Bruno Bernardes de Jesus, Maria A Blasco. Curr Opin Cell Biol 2012
Bruno Bernardes de Jesus, Maria A Blasco. Curr Opin Cell Biol 2012
20
Phenotypes in mTERT⁺/⁻ and mTERT⁻/⁻ mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase.
Margaret A Strong, Sofia L Vidal-Cardenas, Baktiar Karim, Huimin Yu, Nini Guo, Carol W Greider. Mol Cell Biol 2011
Margaret A Strong, Sofia L Vidal-Cardenas, Baktiar Karim, Huimin Yu, Nini Guo, Carol W Greider. Mol Cell Biol 2011
20
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.